Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-07 Sale |
2024-03-07 5:41 pm |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
22,936 | $0 | $0 | 0 (Direct) |
View |
| 2023-10-27 Sale |
2023-10-31 5:00 pm |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
12,778 | $9.82 | $125,480 | 130,079 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-13 4:19 pm |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
16,364 | $15 | $245,460 | 181,317 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 8:25 pm |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
39,271 | $13.62 | $534,938 | 197,681 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-05 Option Award |
2024-03-13 08:03 am |
N/A 2034-03-05 |
Motus GI Holdings Inc. | MOTS | Nelson Sonja Director |
23,205 | $0 | 23,205 (Direct) |
View |
| 2023-12-11 Option Award |
2023-12-11 5:17 pm |
N/A N/A |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
50,000 | $0 | 545,776 (Direct) |
View |
| 2023-07-05 Option Award |
2023-07-07 4:05 pm |
N/A 2033-07-05 |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
389,000 | $0 | 389,000 (Direct) |
View |
| 2023-04-26 Option Award |
2023-04-28 6:00 pm |
N/A N/A |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Fin. & Operating Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 6:16 pm |
N/A 2031-09-01 |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Fin. & Operating Officer |
3,849,596 | $0 | 3,849,596 (Direct) |
View |
Ownership |
2023-01-03 6:32 pm |
N/A 2031-09-01 |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Fin. & Operating Officer |
0 | $0 | 3,849,596 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-11 5:06 pm |
N/A 2032-02-10 |
Motus GI Holdings Inc. | MOTS | Nelson Sonja Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 4:45 pm |
N/A N/A |
Motus GI Holdings Inc. | MOTS | Nelson Sonja Director |
82,500 | $0 | 100,709 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 4:13 pm |
N/A 2031-06-22 |
Motus GI Holdings Inc. | MOTS | Nelson Sonja Director |
68,209 | $0 | 68,209 (Direct) |
View |
| 2021-01-12 Exercise |
2021-01-13 4:19 pm |
N/A 2028-08-27 |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
11,364 | $0 | 181,317 (Direct) |
View |
| 2021-01-12 Exercise |
2021-01-13 4:19 pm |
N/A N/A |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
11,364 | $3.07 | 181,317 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 8:25 pm |
N/A 2028-08-27 |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
22,729 | $0 | 197,681 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 8:25 pm |
N/A N/A |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
22,729 | $3.07 | 197,681 (Direct) |
View |
| 2020-08-02 Tax Withholding |
2020-08-04 9:05 pm |
N/A N/A |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
3,458 | $11.18 | 56,952 (Direct) |
View |
| 2020-08-02 Exercise |
2020-08-04 9:05 pm |
N/A N/A |
NantKwest Inc. | NK | Nelson Sonja Chief Financial Officer |
10,000 | $0 | 56,952 (Direct) |
View |